Paolo Dapavo
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.
Journal: Dermatology and therapy
Published: April 10, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.
Journal: Dermatology and therapy
Published: March 04, 2026
Toward the definition of moderate psoriasis: an expert opinion.
Journal: The Journal of dermatological treatment
Published: February 23, 2026
Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.
Journal: The Journal of dermatological treatment
Published: February 06, 2026
Rituximab-induced nonuremic calciphylaxis in hairy cell leukemia: a singular case.
Journal: Italian journal of dermatology and venereology
Published: September 10, 2025
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review.
Journal: American journal of clinical dermatology
Published: July 30, 2025
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis).
Journal: Clinical and experimental dermatology
Published: June 24, 2025
Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits.
Journal: Dermatology practical & conceptual
Published: June 12, 2025
"Full-naïve" patients: the impact of previous methotrexate, cyclosporine, and acitretin on first-line biologics response in the treatment of moderate-to-severe psoriasis - a monocentric retrospective study.
Journal: Expert opinion on biological therapy
Published: June 09, 2025
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology and therapy
Published: May 23, 2025
Switching to brodalumab after failure of IL-17A inhibitors in psoriatic patients: A real-life multicentre study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 22, 2025
Can't Judge a Book by Its Cover: An Unusual Case of Orbital Swelling.
Journal: International journal of dermatology
Published: April 13, 2025
Last Updated: 09/26/2026